Interaction of the dopaminergic and serotonergic systems significantly influences the risk for multisomatoform disorder: A controlled pilot study

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 8, 2012, Pages 892-896

  Pahl, Lisa ^a   Bernateck, Michael ^a   Jakobi, Jana ^a   Tran, Anh Thu ^a   Volkmann, Lilly ^a   Buers, Dennis ^a   Lehmann, Ulrich ^a   Karst, Matthias ^a   Stuhrmann, Manfred ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ANALYSIS; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTISOMATOFORM DISORDER; PAIN; PILOT STUDY; PYROSEQUENCING; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DOPAMINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEROTONIN; SOMATOFORM DISORDERS;

EID: 84864833988     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0329     Document Type: Article

References (14)

1. Charbit AR, Akerman S, Goadsby PJ. (2011) Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. Pain 152:2365-2376.
2. Edwards RR. (2006) Genetic predictors of acute and chronic pain. Curr Rhematol Rep 8:411-417.
3. Guiard BP, El Mansari M, Merali Z, et al. (2008) Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesion. Int J Neuropsychopharmacol 11:625-639.
4. Jacobi J, Bernateck M, Tran A-T, et al. (2010) Catechol- Omethyltransferase gene polymorphisms are not associated with multisomatoform disorder in a group of German multisomatoform disorder patients and healthy controls. Genet Test Mol Biomarkers 14:293-297.
5. Kato K, Sullivan PF, Evengard B, et al. (2009) A populationbased twin study of functional somatic syndromes. Psychol Med 39:497-505.
6. Kroenke K. (2006) Physical symptom disorder: a simpler diagnostic category for somatization-spec-trumconditions. J Psychosom Res 60:335-339.
7. Lawson K. (2008) Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatr Dis Treat 4:1059-1071.
8. Nackley AG, Shabalina SA, Tchivileva IE, et al. (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314:1930-1933.
9. Omogui S. (2007) The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3-inflammatory profile of pain syndromes. Med Hypotheses 69:1169-1178.
10. Schosser A, Fuchs K, Scharl T, et al. (2010) Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians. World J Biol Psychiatry 11:417-424.
11. Sommer C. (2006) Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep 10:101-106.
12. Sommer S, Hä user W, Gerhold K, et al. (2008) Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain. Schmerz 22:267-282.
13. Treister R, Pud D, Ebstein RP, et al. (2009) Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy human. Pain 147:187-193.
14. Wood PB, Schweinhardt P, Jaeger E, et al. (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25:3576-3582.